a month ago
DMRA
AnalystsBradley CaninoBradley Canino's Stock Forecasts
AnalystsBradley Canino
Analyst Ranking
Top 19%
#1018 out of 5549 analysts
Average Return
+6%
Win Rate
41%56 out of 138
Risk vs Reward
Poor
Good
Bradley Canino's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Summit Therapeutics IncSMMT | +441.18% | $3.74 | $20.24 | 2024-03-26 - 2025-03-25 | Strong Buy |
Relay Therapeutics IncRLAY | +375.25% | $4.00 | $19.01 | 2025-09-04 - 2026-09-03 | Strong Buy |
Celcuity IncCELC | +229.04% | $15.77 | $51.89 | 2024-08-15 - 2025-08-14 | Strong Buy |
Celcuity IncCELC | +213.06% | $15.27 | $47.81 | 2024-10-07 - 2025-10-06 | Strong Buy |
Relay Therapeutics IncRLAY | +181.85% | $3.25 | $9.16 | 2025-02-27 - 2026-02-26 | Strong Buy |
Bradley Canino Analyst Color
Get additional color on Bradley Canino's coverage of popular stocks
2 months ago
KYMR
2 months ago
CELC
3 months ago
REGN
3 months ago
KYMR
3 months ago
URGN
3 months ago
REGN
3 months ago
NBIX
5 months ago
RLAY
6 months ago
CELC
8 months ago
RLAY
8 months ago
DMRA
a year ago
DMRA
a year ago
NUVL
2 years ago
SMMT
2 years ago
NUVL
2 years ago
SMMT
3 years ago
MRUS
3 years ago
CCCC
Bradley Canino's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Damora Therapeutics IncDMRA | 4 | Strong Buy | $60.00 | +173.22% | Maintains | a month ago |
Faeth Therapeutics IncFTH | 1 | Strong Buy | $70.00 | +266.30% | Initiates Coverage On | a month ago |
Kymera Therapeutics IncKYMR | 7 | Strong Buy | $170.00 | +44.59% | Maintains | 2 months ago |
Celcuity IncCELC | 7 | Strong Buy | $175.00 | +157.09% | Maintains | 2 months ago |
Janux Therapeutics IncJANX | 8 | Strong Buy | $55.00 | +218.66% | Maintains | 3 months ago |
Regeneron Pharmaceuticals IncREGN | 2 | Strong Buy | $1,030.00 | +26.21% | Maintains | 3 months ago |
Summit Therapeutics IncSMMT | 7 | Strong Buy | $38.00 | +147.88% | Maintains | 3 months ago |
Urogen Pharma LtdURGN | 1 | Strong Buy | $42.00 | +23.86% | Maintains | 3 months ago |
Tarsus Pharmaceuticals IncTARS | 1 | Strong Buy | $89.00 | +25.78% | Maintains | 3 months ago |
Neurocrine Biosciences IncNBIX | 1 | Strong Buy | $200.00 | +36.99% | Maintains | 3 months ago |
Biogen IncBIIB | 1 | Strong Buy | $280.00 | +10.79% | Maintains | 3 months ago |
Ionis Pharmaceuticals IncIONS | 1 | Strong Buy | $89.00 | +102.46% | Maintains | 3 months ago |
An2 Therapeutics IncANTX | 1 | Strong Buy | $9.00 | +133.16% | Initiates Coverage On | 3 months ago |
Nuvalent IncNUVL | 7 | Hold | $124.00 | +0.03% | Downgrades | 5 months ago |
Relay Therapeutics IncRLAY | 8 | Strong Buy | $26.00 | +38.00% | Maintains | 5 months ago |
Olema Pharmaceuticals IncOLMA | 3 | Strong Buy | $35.00 | +397.16% | Maintains | 6 months ago |
Bicara Therapeutics IncBCAX | 1 | Strong Buy | $42.00 | +140.27% | Initiates Coverage On | 6 months ago |
Tyra Biosciences IncTYRA | 1 | Strong Buy | $54.00 | +150.93% | Initiates Coverage On | 6 months ago |
Pyxis Oncology IncPYXS | 4 | Strong Buy | $8.00 | +334.78% | Maintains | 7 months ago |
Cullinan Therapeutics IncCGEM | 3 | Strong Buy | $30.00 | +102.16% | Initiates Coverage On | 9 months ago |
Crescent Biopharma IncCBIO | 1 | Strong Buy | $35.00 | +163.75% | Initiates Coverage On | 9 months ago |
Black Diamond Therapeutics IncBDTX | 7 | Hold | N/A | N/A | Downgrades | a year ago |
Cg Oncology IncCGON | 1 | Strong Buy | $90.00 | N/A | Initiates Coverage On | a year ago |
Syndax Pharmaceuticals IncSNDX | 7 | Strong Buy | $44.00 | N/A | Reinstates | a year ago |
Oric Pharmaceuticals IncORIC | 2 | Strong Buy | $18.00 | N/A | Assumes | a year ago |
C4 Therapeutics IncCCCC | 5 | Strong Buy | $8.00 | N/A | Initiates Coverage On | a year ago |
Kura Oncology IncKURA | 7 | Hold | N/A | N/A | Initiates Coverage On | a year ago |
Alx Oncology Holdings IncALXO | 7 | Hold | $1.50 | N/A | Maintains | 2 years ago |
Arvinas IncARVN | 6 | Strong Buy | $51.00 | N/A | Maintains | 2 years ago |
Affimed NvAFMDQ | 6 | Hold | $4.00 | N/A | Maintains | 2 years ago |
Zentalis Pharmaceuticals IncZNTL | 17 | Strong Buy | $10.00 | N/A | Maintains | 2 years ago |
Merus NvMRUS | 7 | Strong Buy | $99.00 | N/A | Maintains | 2 years ago |
Blueprint Medicines CorpBPMC | 6 | Strong Buy | $130.00 | N/A | Maintains | 3 years ago |
Deciphera Pharmaceuticals IncDCPH | 6 | Strong Buy | $23.00 | N/A | Maintains | 3 years ago |
Theseus Pharmaceuticals IncTHRX | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 4 years ago |
Turning Point Therapeutics IncTPTX | 2 | Hold | $45.00 | N/A | Maintains | 5 years ago |
Mersana Therapeutics IncMRSN | 1 | Hold | $450.00 | N/A | Initiates Coverage On | 6 years ago |
Seagen IncSGEN | 1 | Hold | $145.00 | N/A | Initiates Coverage On | 6 years ago |
Zymeworks IncZYME | 1 | Buy | $55.00 | N/A | Initiates Coverage On | 6 years ago |
Epizyme IncEPZM | 1 | Buy | $13.00 | N/A | Initiates Coverage On | 6 years ago |
Exelixis IncEXEL | 1 | Buy | $30.00 | N/A | Initiates Coverage On | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.